Andrey Grechko
Research Subjects
Andrey Grechko has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexey Yakovlev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
3 shared publications - Levan B. Berikashvili
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
3 shared publications - Mikhail Ya. Yadgarov
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
3 shared publications - Petr A. Polyakov
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
3 shared publications - Valery V. Likhvantsev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
3 shared publications - A. N. Kuzovlev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 7864
Critical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness
Background/Objectives: A globally recognized definition of chronic critical illness (CCI) is lacking. Temporal criteria produce variable estimates, while pathophysiological models emphasize inflammation, catabolism, and immunosuppression (ICS). The relationship between ICS dynamics and mortality remains unclear. Methods: This retrospective single-center cohort study analyzed real-world data from 3374 adult intensive care unit (ICU) patients. CCI was defined by first detection of the ICS triad: C-reactive protein (CRP) >20 mg/L, albumin 9/L within 24 h. CCI days were classified as critical or non-critical. Mortality and mortality density were compared across CCI groups and periods. Results: CCI developed in 820 patients (24.3%) and was associated with higher mortality (relative risk (RR) 5.08) and mortality density (incidence rate ratio (IRR) 4.09). Critical periods comprised 22.15% of CCI patient-days and had higher mortality density than non-critical periods (IRR 4.25) and no CCI (IRR 10.10). Conclusions: CCI appears to be a biologically dynamic condition characterized by alternating critical and non-critical periods. Periods of simultaneous inflammation, catabolism, and immunosuppression are associated with the highest mortality density, while elevated mortality persists even during periods of partial biological compensation. These findings support the concept that the current ICS state may reflect clinically relevant changes in the course of CCI. However, they do not establish diagnostic or predictive performance and require external validation.
- 12 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 7864
Open AccessCritical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness
Background/Objectives: A globally recognized definition of chronic critical illness (CCI) is lacking. Temporal criteria produce variable estimates, while pathophysiological models emphasize inflammation, catabolism, and immunosuppression (ICS). The relationship between ICS dynamics and mortality remains unclear. Methods: This retrospective single-center cohort study analyzed real-world data from 3374 adult intensive care unit (ICU) patients. CCI was defined by first detection of the ICS triad: C-reactive protein (CRP) >20 mg/L, albumin 9/L within 24 h. CCI days were classified as critical or non-critical. Mortality and mortality density were compared across CCI groups and periods. Results: CCI developed in 820 patients (24.3%) and was associated with higher mortality (relative risk (RR) 5.08) and mortality density (incidence rate ratio (IRR) 4.09). Critical periods comprised 22.15% of CCI patient-days and had higher mortality density than non-critical periods (IRR 4.25) and no CCI (IRR 10.10). Conclusions: CCI appears to be a biologically dynamic condition characterized by alternating critical and non-critical periods. Periods of simultaneous inflammation, catabolism, and immunosuppression are associated with the highest mortality density, while elevated mortality persists even during periods of partial biological compensation. These findings support the concept that the current ICS state may reflect clinically relevant changes in the course of CCI. However, they do not establish diagnostic or predictive performance and require external validation.
- Open Access
- 8 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (19) , 3254
The Critical Clock: Time-Dependent Inflammation, Catabolism and Immunosuppression Syndrome Is Associated with ICU Mortality
Background/Objectives: Chronic critical illness (CCI) is increasingly recognized as a major challenge in intensive care, yet its definition remains heterogeneous. The triad of inflammation, catabolism, and immunosuppression (ICS) is central to proposed CCI pathophysiology, but the association between its changing components and prognosis has not been systematically evaluated. We examined whether the current presence of the biomarker-defined ICS syndrome was associated with ICU mortality. Methods: In this retrospective single-center cohort study, we analyzed 820 ICU patients from the Russian Intensive Care Dataset (RICD v3.0) who had at least one episode of the biomarker-defined ICS syndrome, operationally defined by concurrent C-reactive protein > 20 mg/L, albumin < 30 g/L, and absolute lymphocyte count < 0.8 × 109/L within a 24 h period. After the index ICS syndrome event, each patient’s ICU course was classified according to the current syndrome status: ICS syndrome present (all three criteria met) or ICS syndrome absent (at least one criterion not met). We compared organ dysfunction, laboratory parameters, life-support interventions, and mortality between periods with the syndrome present and absent using linear mixed-effects models, generalized estimating equations, and time-dependent Cox regression. Mortality density was calculated per 1000 patient-days. Results: Periods with the ICS syndrome present accounted for 5271 (22.2%) of 23,796 post-index patient-days and periods with the syndrome absent accounted for 18,525 (77.8%). Variables not used to define the syndrome showed greater contemporaneous severity while the ICS syndrome was present, including higher SOFA and SOFA-2 scores, worse neurological status, lower platelet and total protein levels, and more frequent mechanical ventilation initiation (32.8% vs. 23.6%; OR: 1.59, p < 0.001). The ICS syndrome was present at the time of 133 of 243 deaths (54.7%), with a mortality density of 25.23 versus 5.94 per 1000 patient-days (IRR: 4.25, 95% CI: 3.30–5.47). In time-dependent Cox regression, the current presence versus absence of the biomarker-defined ICS syndrome was associated with a higher hazard of ICU death (unadjusted HR: 4.02, 95% CI: 2.14–7.55; adjusted HR: 3.86, 95% CI: 1.86–8.02). Conclusions: In this cohort, the current presence of the biomarker-defined ICS syndrome was associated with substantially higher ICU mortality risk than its absence. These findings support dynamic risk assessment and closer clinical evaluation; however, the biomarker combination may partly reflect contemporaneous illness severity, and the present analysis does not establish a causal effect of syndrome presence or an independent effect of cumulative prior time with the syndrome present.
- 8 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (19) , 3254
Open AccessThe Critical Clock: Time-Dependent Inflammation, Catabolism and Immunosuppression Syndrome Is Associated with ICU Mortality
Background/Objectives: Chronic critical illness (CCI) is increasingly recognized as a major challenge in intensive care, yet its definition remains heterogeneous. The triad of inflammation, catabolism, and immunosuppression (ICS) is central to proposed CCI pathophysiology, but the association between its changing components and prognosis has not been systematically evaluated. We examined whether the current presence of the biomarker-defined ICS syndrome was associated with ICU mortality. Methods: In this retrospective single-center cohort study, we analyzed 820 ICU patients from the Russian Intensive Care Dataset (RICD v3.0) who had at least one episode of the biomarker-defined ICS syndrome, operationally defined by concurrent C-reactive protein > 20 mg/L, albumin < 30 g/L, and absolute lymphocyte count < 0.8 × 109/L within a 24 h period. After the index ICS syndrome event, each patient’s ICU course was classified according to the current syndrome status: ICS syndrome present (all three criteria met) or ICS syndrome absent (at least one criterion not met). We compared organ dysfunction, laboratory parameters, life-support interventions, and mortality between periods with the syndrome present and absent using linear mixed-effects models, generalized estimating equations, and time-dependent Cox regression. Mortality density was calculated per 1000 patient-days. Results: Periods with the ICS syndrome present accounted for 5271 (22.2%) of 23,796 post-index patient-days and periods with the syndrome absent accounted for 18,525 (77.8%). Variables not used to define the syndrome showed greater contemporaneous severity while the ICS syndrome was present, including higher SOFA and SOFA-2 scores, worse neurological status, lower platelet and total protein levels, and more frequent mechanical ventilation initiation (32.8% vs. 23.6%; OR: 1.59, p < 0.001). The ICS syndrome was present at the time of 133 of 243 deaths (54.7%), with a mortality density of 25.23 versus 5.94 per 1000 patient-days (IRR: 4.25, 95% CI: 3.30–5.47). In time-dependent Cox regression, the current presence versus absence of the biomarker-defined ICS syndrome was associated with a higher hazard of ICU death (unadjusted HR: 4.02, 95% CI: 2.14–7.55; adjusted HR: 3.86, 95% CI: 1.86–8.02). Conclusions: In this cohort, the current presence of the biomarker-defined ICS syndrome was associated with substantially higher ICU mortality risk than its absence. These findings support dynamic risk assessment and closer clinical evaluation; however, the biomarker combination may partly reflect contemporaneous illness severity, and the present analysis does not establish a causal effect of syndrome presence or an independent effect of cumulative prior time with the syndrome present.
- Open Access
Temporal Discordance of the Inflammation, Catabolism and Immunosuppression Triad in Chronic Critical Illness
Background and Objectives: Chronic critical illness (CCI) is a growing problem in modern intensive care, though its pathophysiology remains incompletely defined. While the ICS triad is thought to perpetuate organ dysfunction, the temporal interplay between its components has not been studied. The objective was to characterize the temporal dynamics of each component and to assess their synchrony in CCI patients. Materials and Methods: This retrospective cohort study analyzed data from the Russian Intensive Care Dataset (RICD v3.0). Adult ICU patients with at least one documented ICS episode (CRP > 20 mg/L, albumin < 30 g/L, lymphocytes < 0.8 × 109/L within 24 h) were included. Daily binary statuses were generated for each domain using an episode-persistence algorithm. Pairwise concordance was assessed using Cohen’s κ with bootstrap resampling and generalized estimating equation (GEE) models; domain burden, episode frequency, and status combinations were also evaluated. Results: A total of 820 CCI patients contributed 18,525 non-critical patient-days. CRP and albumin domains were persistently positive (median burden 100% both), while lymphocyte positivity was brief (median burden 34.2%) and recurrent (≥2 episodes in 45.1%). CRP and lymphocyte domains were discordant in 81.2% of days (κ = −0.024; OR 0.60; Holm-adjusted p = 0.005); lymphocyte and albumin domains in 77.0% (κ = −0.021; OR 0.49; Holm-adjusted p < 0.001). CRP and albumin were largely concordant (78.5%; κ = 0.299; OR 2.71; Holm-adjusted p < 0.001). Isolated lymphopenia was rare (0.6%), whereas complete compensation was seen in 7.7% of observations. Conclusions: These findings suggest that the ICS triad components follow distinct, temporally discordant trajectories after CCI onset, questioning the view of CCI as a unified state. While periods of complete compensation were observed, their relationship to clinical resolution of CCI requires further investigation.
Open AccessTemporal Discordance of the Inflammation, Catabolism and Immunosuppression Triad in Chronic Critical Illness
Background and Objectives: Chronic critical illness (CCI) is a growing problem in modern intensive care, though its pathophysiology remains incompletely defined. While the ICS triad is thought to perpetuate organ dysfunction, the temporal interplay between its components has not been studied. The objective was to characterize the temporal dynamics of each component and to assess their synchrony in CCI patients. Materials and Methods: This retrospective cohort study analyzed data from the Russian Intensive Care Dataset (RICD v3.0). Adult ICU patients with at least one documented ICS episode (CRP > 20 mg/L, albumin < 30 g/L, lymphocytes < 0.8 × 109/L within 24 h) were included. Daily binary statuses were generated for each domain using an episode-persistence algorithm. Pairwise concordance was assessed using Cohen’s κ with bootstrap resampling and generalized estimating equation (GEE) models; domain burden, episode frequency, and status combinations were also evaluated. Results: A total of 820 CCI patients contributed 18,525 non-critical patient-days. CRP and albumin domains were persistently positive (median burden 100% both), while lymphocyte positivity was brief (median burden 34.2%) and recurrent (≥2 episodes in 45.1%). CRP and lymphocyte domains were discordant in 81.2% of days (κ = −0.024; OR 0.60; Holm-adjusted p = 0.005); lymphocyte and albumin domains in 77.0% (κ = −0.021; OR 0.49; Holm-adjusted p < 0.001). CRP and albumin were largely concordant (78.5%; κ = 0.299; OR 2.71; Holm-adjusted p < 0.001). Isolated lymphopenia was rare (0.6%), whereas complete compensation was seen in 7.7% of observations. Conclusions: These findings suggest that the ICS triad components follow distinct, temporally discordant trajectories after CCI onset, questioning the view of CCI as a unified state. While periods of complete compensation were observed, their relationship to clinical resolution of CCI requires further investigation.
- Open Access
- 1 January 2020
- Published by Moscow State University of Psychology and Education in Counseling Psychology and Psychotherapy
- Vol. 28 (3) , 122-141
Digital Technologies in Rehabilitation of Patients with Focal Brain Injury
Focal damage of the brain leads to cognitive impairments, which sufficiently limit the person’s functional capabilities, which, in turn, can lead to secondary disorders of the emotional and personal sphere and social maladjustment. The need to include cognitive rehabilitation in the system of complex treatment methods for patients with focal brain lesions is generally recognized. The article describes methods of neurorehabilitation based on high technologies and indicates their place in the general rehabilitation process. Data yielded by domestic and foreign studies on the effectiveness of digital technologies in the cognitive rehabilitation of patients with focal brain lesions is presented.
- 1 January 2020
- Published by Moscow State University of Psychology and Education in Counseling Psychology and Psychotherapy
- Vol. 28 (3) , 122-141
Open AccessDigital Technologies in Rehabilitation of Patients with Focal Brain Injury
Focal damage of the brain leads to cognitive impairments, which sufficiently limit the person’s functional capabilities, which, in turn, can lead to secondary disorders of the emotional and personal sphere and social maladjustment. The need to include cognitive rehabilitation in the system of complex treatment methods for patients with focal brain lesions is generally recognized. The article describes methods of neurorehabilitation based on high technologies and indicates their place in the general rehabilitation process. Data yielded by domestic and foreign studies on the effectiveness of digital technologies in the cognitive rehabilitation of patients with focal brain lesions is presented.